Yes I wholeheartedly echo your sentiments @col69 and as @The Yankee points out vested interests on all levels will seek financial reward rather than sound science The submission from Lassman Law reads just like any “experts report”. The problem arises when there’s no “Conflict of Interest” statement to accompany the submission Now that would be revealing too much. Every published scientific paper must now disclose who supports and funds their research. The same should be true for all FDA submissions
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-249
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |